Potential changes in the conduct of clinical trials in relation to COVID-19
17.03.2020.
With regard to trial conduct during COVID-19 pandemic, joint guidance developed by the European Commission, Europe Medicines Agency and the Heads of Medicines Agency (hereinafter – EU Guidance) should be followed. With...